Cell Medica's Series C Round

Cell Medica raised a round of funding on March 16, 2017.

Cell Medica develops, manufactures and markets cellular immunotherapy products for the treatment of cancer and infections. The Company employs technologies to develop cell-based therapies with the pot…

Articles about Cell Medica's Series C Round: